Results 71 to 80 of about 34,291 (274)

Cytotoxic and Antileishmanial Potential of Pilocarpus microphyllus Essential Oil: In Vitro and In Silico Study

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
Jaborandi (Pilocarpus microphyllus) essential oil is obtained by removal and characterization using GC‐MS, revealing γ‐cadinene and trans‐caryophyllene as major constituents. The oil exhibits biological activity, with antifungal action against Candida spp.
Juniel Cruz Silva, Maria Gabriela Araújo Mendes, Paulo Sérgio de Araujo Sousa, Alyne Rodrigues de Araújo Nobre, Michel Muálem de Moraes Alves, Fernando Aécio de Amorim Carvalho, Tatiane Caroline Daboit, José de Sousa Lima Neto, Ygor Victor Ferreira Pinheiro, Ytallo da Costa Sousa, Edymilaís da Silva Sousa, José Delano Barreto Marinho Filho, Ana Jérsia Araújo, Francisco Artur Silva Filho, Sidney Gonçalo de Lima, Leiz Maria Costa Véras   +15 more
wiley   +1 more source

Cutaneous Cryptococcosis Masquerading Molluscum Contagiosum In A Patient With HIV Disease

Indian Journal of Dermatology, 2001
Cryptococcosis, though quite rare, occurs throughout the world. Even more rare is to have cutaneous cryptococcosis. We describe in this case report, a case of cutaneous cryptococcosis in a HIV seropositive individual who had skin lesions over the face ...
Thappa Devinder Mohan, Karthikeyan Kaliaperumal, Kaviarasan P.K, Sethuraman Gomathy   +3 more
doaj  

Csf in 85 patients with aids and cns cryptococcosis

Arquivos de Neuro-Psiquiatria, 1992
In an eight years time period (July 1984-June 1992) CSF samples of 40718 patients were studied, and 610 were from patients with AIDS clinically diagnosed and immunologically confirmed through HIV antibodies detection.
J. A. Livramento, L. R. Machado, J. P. S. Nóbrega, H. R. Gomes, L. S. Vianna, A. Spina-frança   +5 more
doaj   +1 more source

Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review.

, 2012
OBJECTIVES: Given the imperative to scale up integrated tuberculosis (TB) and HIV services in settings where both are of major public health importance, we aimed to synthesise knowledge concerning implementation of TB/HIV service integration.
Atun, Briggs, Dixon-Woods, Dong, Gandhi, Gunneberg, Harris, Hausler, Laserson, Levin, Maher, Martinot, Micek, Miti, Moher, Ramachandran, Shakarishvilli, Shetty, Shrestha, Ssemafumu, Sutton, Terris-Prestholt, The World Bank Group, Thomas, USAID, Uyei, Van Rie, Vassall, Vijay, Wandwalo, WHO, WHO, WHO, WHO, WHO, WHO, Zachariah   +36 more
core   +1 more source

Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Advanced HIV disease (AHD) remains a leading cause of mortality in Latin America and the Caribbean (LAC), driven by late diagnosis, treatment gaps and structural barriers, particularly among key populations and children. Persistent disparities in healthcare access, stigma, and limited health system capacity highlight the need for ...
Evelina Chapman, Omar Sued, Jorge O. Maia Barreto, Claudia P. Cortes, Brenda Crabtree Ramírez, José E. Vidal, Antonio Camiro‐Zúñiga, Freddy Perez   +7 more
wiley   +1 more source

Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006 [PDF]

, 2009
Deaths caused by systemic mycoses such as paracoccidioidomycosis, cryptococcosis, histoplasmosis, candidiasis, aspergillosis, coccidioidomycosis and zygomycosis amounted to 3,583 between 1996-2006 in Brazil. When analysed as the underlying cause of death,
LAURENTI, Ruy, PRADO, Marli, SILVA, Marcelo Barbosa da, TABORDA, Carlos P, TRAVASSOS, Luiz R   +4 more
core   +3 more sources

A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Despite significant progress in HIV care globally, a persistent 30–40% of people present with advanced HIV disease with ≤200 CD4 cells/µl. The Visitect CD4 Advanced Disease platform is a point‐of‐care CD4 test being implemented in resource‐limited settings.
Elizabeth Nalintya, Elizabeth L. Schwartz, Patricia Nerima, Ann Fieberg, Sarah M. Najjuka, Ruth E. Ajilong, Tessa Adzemovic, Olive Namakula, Atukunda Mucunguzi, Kiiza Kandole Tadeo, Mark Oilor, Preethiya Sekar, Alice Lehman, Bruce Larson, Biyue Dai, David B. Meya, David R. Boulware, Radha Rajasingham, the ENCORE team   +18 more
wiley   +1 more source

End-stage liver disease Is a strong predictor of early mortality in cryptococcosis [PDF]

, 2015
Background. Cryptococcosis in the setting of end-stage liver disease (ESLD) has been associated with high mortality. We sought to compare the outcome of cryptococcal disease in patients with ESLD to that of human immunodeficiency virus (HIV)-positive ...
Powderly, William G, Raval, Krunal, Spec, Andrej   +2 more
core   +2 more sources

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 2, Page 222-230, January 2026.
Between 2012 and 2021 in France, invasive fungal diseases affected 1 in 50 patients with alcohol‐related hepatitis and at least two hepatic or extrahepatic complications, with substantially higher mortality than bacterial pneumonia. These findings support targeted screening and early antifungal strategies in this population, as currently recommended ...
Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Philippe Sogni, Fanny Lanternier, Alexandre Alanio, Vincent Mallet, Demosthenes Research Group   +9 more
wiley   +1 more source

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis. [PDF]

, 2018
Background: Current guidelines recommend screening all people living with human immunodeficiency virus (PLHIV) who have a CD4 count ≤100 cells/µL for cryptococcal antigen (CrAg) to identify those patients who could benefit from preemptive fluconazole ...
Chiller, Tom, Doherty, Meg, Ford, Nathan, Greene, Greg, Jarvis, Joseph N, Meintjes, Graeme, Migone, Chantal, Shubber, Zara, Vitoria, Marco   +8 more
core   +1 more source